{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:10:27Z","timestamp":1750219827331,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":21,"publisher":"ACM","license":[{"start":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T00:00:00Z","timestamp":1693699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health (NIH) NIGMS","award":["R00GM135488"],"award-info":[{"award-number":["R00GM135488"]}]}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,3]]},"DOI":"10.1145\/3584371.3612977","type":"proceedings-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T18:52:30Z","timestamp":1696445550000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating Drug Effectiveness for Antihypertensives in Heart Failure Prognosis: Leveraging Composite Clinical Endpoints and Biomarkers from Electronic Health Records"],"prefix":"10.1145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6775-8623","authenticated-orcid":false,"given":"Shaika","family":"Chowdhury","sequence":"first","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9359-6525","authenticated-orcid":false,"given":"Yongbin","family":"Chen","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-8468","authenticated-orcid":false,"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3237-4954","authenticated-orcid":false,"given":"Qiying","family":"Dai","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3900-1217","authenticated-orcid":false,"given":"Yue","family":"Yu","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0066-9524","authenticated-orcid":false,"given":"Nansu","family":"Zong","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}]}],"member":"320","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"e_1_3_2_1_1_1","first-page":"368","volume":"2016","author":"Ziaeian B","unstructured":"Ziaeian B , Fonarow GC. Epidemiology and aetiology of heart failure. Nature Reviews Cardiology. 2016 Jun;13(6): 368 -- 378 . Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nature Reviews Cardiology. 2016 Jun;13(6):368--78.","journal-title":"Nature Reviews Cardiology."},{"key":"e_1_3_2_1_2_1","doi-asserted-by":"crossref","unstructured":"Writing Group Members Thom T Haase N Rosamond W Howard VJ Rumsfeld J Manolio T Zheng ZJ Flegal K O'Donnell C Kittner S. Heart disease and stroke statistics---2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006 Feb 14;113(6):e85-151.  Writing Group Members Thom T Haase N Rosamond W Howard VJ Rumsfeld J Manolio T Zheng ZJ Flegal K O'Donnell C Kittner S. Heart disease and stroke statistics---2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006 Feb 14;113(6):e85-151.","DOI":"10.1161\/CIRCULATIONAHA.105.171600"},{"key":"e_1_3_2_1_3_1","doi-asserted-by":"crossref","unstructured":"Ponikowski P Anker SD AlHabib KF Cowie MR Force TL Hu S Jaarsma T Krum H Rastogi V Rohde LE Samal UC. Heart failure: preventing disease and death worldwide. ESC heart failure. 2014 Sep;1(1):4--25.  Ponikowski P Anker SD AlHabib KF Cowie MR Force TL Hu S Jaarsma T Krum H Rastogi V Rohde LE Samal UC. Heart failure: preventing disease and death worldwide. ESC heart failure. 2014 Sep;1(1):4--25.","DOI":"10.1002\/ehf2.12005"},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"crossref","unstructured":"Bergethon KE Ju C DeVore AD Hardy NC Fonarow GC Yancy CW Heidenreich PA Bhatt DL Peterson ED Hernandez AF. Trends in 30-day readmission rates for patients hospitalized with heart failure: findings from the get with the guidelines-heart failure registry. Circulation: Heart Failure. 2016 Jun;9(6):e002594.  Bergethon KE Ju C DeVore AD Hardy NC Fonarow GC Yancy CW Heidenreich PA Bhatt DL Peterson ED Hernandez AF. Trends in 30-day readmission rates for patients hospitalized with heart failure: findings from the get with the guidelines-heart failure registry. Circulation: Heart Failure. 2016 Jun;9(6):e002594.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002594"},{"key":"e_1_3_2_1_5_1","volume-title":"Global status report on noncommunicable diseases","author":"World Health Organization","year":"2014","unstructured":"World Health Organization . Global status report on noncommunicable diseases 2014 . World Health Organization ; 2014. World Health Organization. Global status report on noncommunicable diseases 2014. World Health Organization; 2014."},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"crossref","unstructured":"Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. Journal of hypertension. 2007 May 1;25(5):951--8.  Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. Journal of hypertension. 2007 May 1;25(5):951--8.","DOI":"10.1097\/HJH.0b013e3280bad9b4"},{"key":"e_1_3_2_1_7_1","first-page":"1410","volume":"2","author":"Trialists' Collaboration BP.","unstructured":"Trialists' Collaboration BP. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Archives of internal medicine. 2005 Jun 2 7;165(12): 1410 -- 1419 . Trialists' Collaboration BP. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Archives of internal medicine. 2005 Jun 27;165(12):1410--9.","journal-title":"Jun"},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"crossref","unstructured":"Arwood MJ Cavallari LH Duarte JD. Pharmacogenomics of hypertension and heart disease. Current hypertension reports. 2015 Sep;17:1--2.  Arwood MJ Cavallari LH Duarte JD. Pharmacogenomics of hypertension and heart disease. Current hypertension reports. 2015 Sep;17:1--2.","DOI":"10.1007\/s11906-015-0586-5"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"crossref","unstructured":"Hamburger RJ Fye C Lakshman R Gottdiener J Ramirez EA. Single-Drug Therapy for Hypertension in Men-A Comparison of Six Antihypertensive Agents with Placebo. New England Journal of Medicine. 1993 Apr 1;328(13):914--21.  Hamburger RJ Fye C Lakshman R Gottdiener J Ramirez EA. Single-Drug Therapy for Hypertension in Men-A Comparison of Six Antihypertensive Agents with Placebo. New England Journal of Medicine. 1993 Apr 1;328(13):914--21.","DOI":"10.1056\/NEJM199304013281303"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"crossref","unstructured":"Adam G Ramp\u00e1\u0161ek L Safikhani Z Smirnov P Haibe-Kains B Goldenberg A. Machine learning approaches to drug response prediction: challenges and recent progress. NPJ precision oncology. 2020 Jun 15;4(1):19.  Adam G Ramp\u00e1\u0161ek L Safikhani Z Smirnov P Haibe-Kains B Goldenberg A. Machine learning approaches to drug response prediction: challenges and recent progress. NPJ precision oncology. 2020 Jun 15;4(1):19.","DOI":"10.1038\/s41698-020-0122-1"},{"key":"e_1_3_2_1_11_1","unstructured":"Peters BJ Klungel OH de Boer A Stricker BH Maitland-van der Zee AH. Pharmacogenetics of cardiovascular drug therapy. Clinical cases in mineral and bone metabolism. 2009 Jan;6(1):55.  Peters BJ Klungel OH de Boer A Stricker BH Maitland-van der Zee AH. Pharmacogenetics of cardiovascular drug therapy. Clinical cases in mineral and bone metabolism. 2009 Jan;6(1):55."},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"crossref","unstructured":"Eadon MT Kanuri SH Chapman AB. Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment. Expert review of precision medicine and drug development. 2018 Jan 2;3(1):33--47.  Eadon MT Kanuri SH Chapman AB. Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment. Expert review of precision medicine and drug development. 2018 Jan 2;3(1):33--47.","DOI":"10.1080\/23808993.2018.1420419"},{"key":"e_1_3_2_1_13_1","doi-asserted-by":"crossref","unstructured":"Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. Journal of cardiac failure. 2001 Jun 1;7(2):176--82.  Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. Journal of cardiac failure. 2001 Jun 1;7(2):176--82.","DOI":"10.1054\/jcaf.2001.25652"},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"crossref","unstructured":"Bettencourt P. NT-proBNP and BNP: biomarkers for heart failure management. European journal of heart failure. 2004 Mar;6(3):359--63.  Bettencourt P. NT-proBNP and BNP: biomarkers for heart failure management. European journal of heart failure. 2004 Mar;6(3):359--63.","DOI":"10.1016\/j.ejheart.2004.01.008"},{"key":"e_1_3_2_1_15_1","first-page":"614","volume":"1","author":"Ibrahim NE","unstructured":"Ibrahim NE , Januzzi Jr JL. Established and emerging roles of biomarkers in heart failure. Circulation research. 2018 Aug 1 7;123(5): 614 -- 629 . Ibrahim NE, Januzzi Jr JL. Established and emerging roles of biomarkers in heart failure. Circulation research. 2018 Aug 17;123(5):614--29.","journal-title":"Aug"},{"key":"e_1_3_2_1_16_1","doi-asserted-by":"crossref","unstructured":"Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. American heart journal. 2006 Nov 1;152(5):828--34.  Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. American heart journal. 2006 Nov 1;152(5):828--34.","DOI":"10.1016\/j.ahj.2006.08.021"},{"key":"e_1_3_2_1_17_1","doi-asserted-by":"crossref","unstructured":"Elman JL. Finding structure in time. Cognitive science. 1990 Mar;14(2):179--211.  Elman JL. Finding structure in time. Cognitive science. 1990 Mar;14(2):179--211.","DOI":"10.1207\/s15516709cog1402_1"},{"key":"e_1_3_2_1_18_1","first-page":"2673","volume":"1997","author":"Schuster M","unstructured":"Schuster M , Paliwal KK. Bidirectional recurrent neural networks. IEEE transactions on Signal Processing. 1997 Nov;45(11): 2673 -- 2681 . Schuster M, Paliwal KK. Bidirectional recurrent neural networks. IEEE transactions on Signal Processing. 1997 Nov;45(11):2673--81.","journal-title":"Signal Processing."},{"volume-title":"Proceedings of the IEEE. 1998Nov;86(11)","author":"LeCun Y","key":"e_1_3_2_1_19_1","unstructured":"LeCun Y , Bottou L , Bengio Y , Haffner P. Gradient-based learning applied to document recognition . Proceedings of the IEEE. 1998Nov;86(11) :2278--324. LeCun Y, Bottou L, Bengio Y, Haffner P. Gradient-based learning applied to document recognition. Proceedings of the IEEE. 1998Nov;86(11):2278--324."},{"key":"e_1_3_2_1_20_1","unstructured":"Vaswani A Shazeer N Parmar N Uszkoreit J Jones L Gomez AN Kaiser \u0141 Polosukhin I. Attention is all you need. Advances in neural information processing systems. 2017;30.  Vaswani A Shazeer N Parmar N Uszkoreit J Jones L Gomez AN Kaiser \u0141 Polosukhin I. Attention is all you need. Advances in neural information processing systems. 2017;30."},{"key":"e_1_3_2_1_21_1","unstructured":"Nair V Hinton GE. Rectified linear units improve restricted boltzmann machines. InIcml 2010 Jan 1.  Nair V Hinton GE. Rectified linear units improve restricted boltzmann machines. InIcml 2010 Jan 1."}],"event":{"name":"BCB '23: 14th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics","sponsor":["SIGBio ACM Special Interest Group on Bioinformatics"],"location":"Houston TX USA","acronym":"BCB '23"},"container-title":["Proceedings of the 14th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3584371.3612977","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3584371.3612977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T16:46:26Z","timestamp":1750178786000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3584371.3612977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,3]]},"references-count":21,"alternative-id":["10.1145\/3584371.3612977","10.1145\/3584371"],"URL":"https:\/\/doi.org\/10.1145\/3584371.3612977","relation":{},"subject":[],"published":{"date-parts":[[2023,9,3]]},"assertion":[{"value":"2023-10-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}